Machine-learning models utilizing show improved prediction of hypoglycemic medication in Type 2 diabetes.

The effectiveness and side effects of Type 2 diabetes (T2D) medication are related to individual genetic background. SNPs and were introduced to machine-learning models to improve the performance of T2D medication prediction. Two multilabel classification models, ML-KNN and WRank-SVM, trained with clinical data and / SNPs were evaluated. Prediction performance was evaluated with Hamming loss, one-error, coverage, ranking loss and average precision. The average precision of ML-KNN and WRank-SVM using clinical data was 92.74% and 92.9%, respectively. Combined with , the average precision dropped to 88.84% and 89.93%, respectively. While combined with , the average precision was enhanced to 97.96% and 97.82%, respectively. Results suggest that can improve the performance of ML-KNN and WRank-SVM models in predicting T2D medication performance.